All News

OXFORD, England -- The cardiovascular risk of rofecoxib (Vioxx), the now-withdrawn Cox-2 inhibitor, increased from the start of treatment rather than after an 18-month delay, found researchers here.

INDIANAPOLIS -- When metastatic testicular cancer progresses despite initial chemotherapy, including a cisplatin-based combination, a high-dose salvage regimen with stem-cell rescue can lead to relapse-free complete responses.